These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Myocardial "equilibration processes" and myocardial energy turnover during initiation of artificial cardiac arrest with cardioplegic solution - reasons for a sufficiently long cardioplegic perfusion. Preusse CJ, Gebhard MM, Bretschneider HJ. Thorac Cardiovasc Surg; 1981 Apr; 29(2):71-6. PubMed ID: 6166077 [Abstract] [Full Text] [Related]
45. The protective effect of puerarin against myocardial reperfusion injury. Study on cardiac function. Fan LL, Sun LH, Li J, Yue XH, Yu HX, Wang SY. Chin Med J (Engl); 1992 Jan; 105(1):11-7. PubMed ID: 1576864 [Abstract] [Full Text] [Related]
47. The relationship between coronary pressure during reperfusion and myocardial recovery after hypothermic cardioplegia. Rosenfeldt FL, Rabinov M, Little P, Campbell G. J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 1):414-24. PubMed ID: 3489137 [Abstract] [Full Text] [Related]
58. Oxygen utilization during isovolumic pressure-volume loading: effects of prolonged extracorporeal circulation and cardioplegic arrest. Krukenkamp I, Silverman N, Sorlie D, Pridjian A, Feinberg H, Levitsky S. Ann Thorac Surg; 1986 Apr; 41(4):407-12. PubMed ID: 3963917 [Abstract] [Full Text] [Related]
59. Experimental evaluation of myocardial protective effect of prostacyclin analog (OP-41483) as an adjunct to cardioplegic solution. Nomura F, Matsuda H, Shirakura R, Ohtani M, Sawa Y, Nakano S, Kawashima Y. J Thorac Cardiovasc Surg; 1991 May; 101(5):860-5. PubMed ID: 2023442 [Abstract] [Full Text] [Related]